Risk is greater in patients managed with watchful waiting than in those who undergo radical treatment.
Only 10% of men aged 45-69 years who progress from no or mild to moderate or severe lower urinary tract symptoms are treated, study finds.
Study reveals circadian variation in phosphate, parathyroid hormone, and 25-hydroxyvitamin D levels in patients with end-stage renal disease.
Improved renal function may contribute to the decline in a glycoprotein that inhibits bone formation.
Physicians are advised to use this approach in patients with interstitial cystitis/bladder pain syndrome prior to the start of medical treatment.